Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
06:23am, Monday, 03'rd Jun 2024
Dividend-paying stocks tend to outperform their non-dividend-paying cousins. Bristol Myers Squibb is a leading pharmaceutical company that has raised its dividend payout for 15 consecutive years.
Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss
04:06am, Monday, 03'rd Jun 2024
S&P 500 operating EPS growth was solid at 6.4% in Q1, but critics argue that excluding profits from top tech stocks shows less impressive growth. Bristol-Myers Squibb faces a soft growth outlook, but
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
08:09am, Sunday, 02'nd Jun 2024
Treatment with Bristol Myers Squibb's immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer had spread to lymph nodes had better outcomes than those who did not get the dru
5 Relatively Secure And Cheap Dividend Stocks To Invest In - June 2024
09:00am, Saturday, 01'st Jun 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASCO24--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced.
Bristol Myers (BMY) Gets EC Nod for Opdivo Label Expansion
01:16pm, Thursday, 30'th May 2024
Bristol Myers' (BMY) Opdivo combination regimen receives the European Commission's approval for the first-line treatment of unresectable or metastatic urothelial carcinoma.
US FDA allows use of Bristol's cell therapy for rare blood cancer
11:59am, Thursday, 30'th May 2024
The U.S. Food and Drug Administration has allowed expanded use of Bristol Myers Squibb's cell therapy, Breyanzi, for an aggressive and rare type of blood cancer that affects the body's disease fightin
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymph
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Thursday, 30'th May 2024
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
7 Underappreciated Stocks With 25% Return Potential in 2024
06:10am, Thursday, 30'th May 2024
Whether investors refer to them as undervalued or hidden gems, underappreciated stocks are always worth considering. Investors have made fortunes, large and small, by identifying underappreciated sha
Bristol Myers Squibb Shares Cross 6% Yield Mark
08:12pm, Wednesday, 29'th May 2024
In trading on Wednesday, shares of Bristol Myers Squibb were yielding above the 6% mark based on its quarterly dividend (annualized to $2.4), with the stock changing hands as low as $39.94 on the day.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CheckMate--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Li
Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb
08:00am, Tuesday, 28'th May 2024
SAN FRANCISCO--(BUSINESS WIRE)-- #CADD--Menten AI, Inc., a biotechnology company with a generative AI platform for design and optimization of peptide macrocycles, today announced the completion of a p
3 Blue-Chip Stocks to Buy at 52-Week Lows in May
06:13am, Monday, 27'th May 2024
It may seem risky to look for blue-chip stocks at a 52-week low. After all, most blue chips are renowned for their ability to trade within a stable range and deliver growth.
Sell Alert: 2 Dividend Stocks To Sell In May And Go Away
11:03am, Friday, 24'th May 2024
The "Sell in May and go away" adage suggests selling stocks in May and returning in November, but historical data shows that June and July have been strong months. September is consistently the worst
